Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05579769
What this trial is testing

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

Who this might be right for
Hematologic MalignancyMyeloid Malignancy
St. Jude Children's Research Hospital 3
Testing effectiveness (Phase 2)Study completedNCT04857645
What this trial is testing

ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients

Who this might be right for
MDSAML
Groupe Francophone des Myelodysplasies 57
Not applicableLooking for participantsNCT04249830
What this trial is testing

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

Who this might be right for
Hematologic Diseases
Alice Bertaina 204
Testing effectiveness (Phase 2)Study completedNCT03068819
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 62
Testing effectiveness (Phase 2)UnknownNCT04501354
What this trial is testing

Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients

Who this might be right for
Osteoporosis
Ahmad Jabir Rahyussalim 5
Not applicableStudy completedNCT02025972
What this trial is testing

Allogeneic Umbilical Cord Blood Therapy in Children With CP

Who this might be right for
Cerebral Palsy
MinYoung Kim, M.D. 10
Early research (Phase 1)UnknownNCT01686139
What this trial is testing

Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers

Who this might be right for
Type I Diabetes Mellitus With UlcerType II Diabetes Mellitus With Ulcer
Sheba Medical Center 12
Not applicableStudy completedNCT00476229
What this trial is testing

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

Who this might be right for
LymphomaLeukemia
M.D. Anderson Cancer Center 20
Early research (Phase 1)Study completedNCT00228839
What this trial is testing

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Emory University
Testing effectiveness (Phase 2)Study completedNCT03818854
What this trial is testing

Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome

Who this might be right for
Respiratory Distress Syndrome, Adult
Michael A. Matthay 120
Not applicableStudy completedNCT03713073
What this trial is testing

Clinical and Histological Outcomes of Allogenic Amnion Chorion Membrane in the Healing of Free Gingival Graft Donor Site

Who this might be right for
Palatal Wound
The University of Texas Health Science Center, Houston 19
Testing effectiveness (Phase 2)Study completedNCT00766883
What this trial is testing

Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant

Who this might be right for
DistressHematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC) 195
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Not applicableActive Not RecruitingNCT07155369
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
The Affiliated Hospital of Xuzhou Medical University 18
Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001853
What this trial is testing

Allogeneic BM-MSCs in Patients With Painful Lumbar Facet Arthropathy

Who this might be right for
Facet-Mediated Low Back PainLumbar Facet Joint Osteoarthritis
Mayo Clinic 40
Early research (Phase 1)WithdrawnNCT00524953
What this trial is testing

Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT

Who this might be right for
Allogeneic Transplantation (Non T-cell Depleted)
Hadassah Medical Organization
Testing effectiveness (Phase 2)WithdrawnNCT02587572
What this trial is testing

Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial

Who this might be right for
Metabolic DiseaseEndothelial Dysfunction
Longeveron Inc.
Early research (Phase 1)Study completedNCT00476177
What this trial is testing

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

Who this might be right for
Hematologic Malignancy
Dana-Farber Cancer Institute 25
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation